The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis

By Poole Chris D.   Tetlow Tony   McEwan Phil   Holmes Paul   Currie Craig J.  

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-02 ,pp. : 41-48

Informa Healthcare

Access to resources Recommend Favorite

The outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis

By Currie Craig J.   Poole Chris D.   Tetlow Tony   Holmes Paul   McEwan Phil  

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-02 ,pp. : 33-39

Informa Healthcare

Access to resources Recommend Favorite

The when and how of insulin initiation in type 2 diabetes

By Liebl Andreas  

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-01 ,pp. : 129-132

Informa Healthcare

Access to resources Recommend Favorite

Recognition of fasting or overall hyperglycaemia when starting insulin treatment in patients with type 2 diabetes in general practice

By Vähätalo Markku   Rönnemaa Tapani   Viikari Jorma  

Scandinavian Journal of Primary Health Care, Vol. 25, Iss. 3, 2007-01 ,pp. : 147-153

Informa Healthcare

Access to resources Recommend Favorite

Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes

By Jendle J.   Torffvit O.   Ridderstråle M.   Lammert M.   Ericsson Å.   Bøgelund M.  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 917-923

Informa Healthcare

Access to resources Recommend Favorite